Apimeds Pharmaceuticals US, Inc. (APUS)

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	26	-	-	-	-
Debt / Equity Ratio	0.06	-0.50	8.38	-0.96	-1.68
Quick Ratio	6.41	0.00	3.33	0.02	16.09
Current Ratio	8.34	0.01	3.42	0.02	16.16
Return on Assets (ROA)	-69.29%	-366.30%	-218.17%	-448.25%	-
Return on Invested Capital (ROIC)	-78.61%	-	-348.55%	-611.12%	-
Return on Capital Employed (ROCE)	-63.10%	126.10%	-250.20%	203.90%	-631.20%
Buyback Yield / Dilution	-29.09%	-71.89%	-19.55%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q